{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:18:36Z","timestamp":1789499916076,"version":"build-2803163510"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"42","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"abstract":"<jats:p>\n                    Systemic inflammatory proteins have been reported to be related to inflammatory bowel disease (IBD) in previous observational research. However, their causal links remain obscure. Herein, we performed a Mendelian randomization (MR) analysis to analyze the causality between systemic inflammatory proteins and IBD. Genetic variants related to systemic inflammatory proteins were extracted from a meta-analysis of genome-wide association study (GWAS) data of 8293 European participants. Summary statistics of IBD diverse subtypes were obtained from the international IBD genetic consortium (IIBDGC). We conducted multi-omics method and MR study to detect the causal links through integrating GWAS and protein quantity trait loci (pQTL) data. Inverse variance weighted (IVW) approach was utilized as the dominated analysis method. Moreover, complementary approaches such as MR-Egger intercept test, Cochran\n                    <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                    test and leave-one-out analysis were utilized to validate pleiotropy and heterogeneity. Finally, single-cell RNA-sequencing analysis was performed to detect the expression of significant genes. For IBD, IVW estimates suggested that genetically predicted IL-10 and IL-13 were suggestively associated with an elevated risk of IBD (IL-10: OR: 1.12, 95% CI: 1.00\u20131.24,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.04; IL-13: OR: 1.09, 95% CI: 1.01\u20131.18,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.023), while CXCL10 was suggestively linked to a lower risk of IBD (CXCL10: OR: 0.90, 95% CI: 0.82\u20130.99,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.037). For Crohn disease (CD), the IVW approach provided evidence to sustain that genetically determined IL-13 and CCL3 had a suggestive association with a higher risk of CD (IL-13: OR: 1.13, 95% CI: 1.02\u20131.26,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.023; CCL3: OR: 1.22, 95% CI: 1.03\u20131.45,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.018). Sensitivity analysis did not explore any heterogeneity and pleiotropy. Our findings supported the causal relationships between 4 specific inflammatory proteins (IL-10, IL-13, CXCL10, and CCL3) and the risk of IBD and CD, thereby providing promising biomarkers of various subtypes stratification and new insights for the prevention and therapeutic target of IBD.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045312","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:02:50Z","timestamp":1762210970000},"page":"e45312","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Genetic predisposition to systemic inflammatory proteins is causally associated with inflammatory bowel disease: Insights from multi-omics association study and single-cell RNA-sequencing analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Jingwen","family":"Liu","sequence":"first","affiliation":[{"name":"Longyou People\u2019s Hospital Affiliated with Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Quzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9627-568X","authenticated-orcid":false,"given":"Renbing","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Urology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People\u2019s Hospital, Quzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12328-017-0813-5","article-title":"Gut microbiota in the pathogenesis of inflammatory bowel disease.","volume":"11","author":"Nishida","year":"2018","journal-title":"Clin J Gastroenterol"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jsxm.2022.03.615","article-title":"The prevalence and associated risk factors of erectile dysfunction in patients with inflammatory bowel disease: a systematic review and meta-analysis.","volume":"19","author":"Wu","year":"2022","journal-title":"J Sex Med"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cgh.2008.10.021","article-title":"Evidence of endothelial dysfunction in patients with inflammatory bowel disease.","volume":"7","author":"Roifman","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.cgh.2020.01.028","article-title":"Changing global epidemiology of inflammatory bowel diseases: sustaining health care delivery into the 21st century.","volume":"18","author":"Ananthakrishnan","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3390\/ijms24021526","article-title":"Pathophysiology of inflammatory bowel disease: innate immune system.","volume":"24","author":"Saez","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"ii3","DOI":"10.1093\/ecco-jcc\/jjac034","article-title":"Interleukin-23 in the pathogenesis of inflammatory bowel disease and implications for therapeutic intervention.","volume":"16","author":"Sewell","year":"2022","journal-title":"J Crohns Colitis"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","article-title":"Inflammatory bowel disease: pathogenesis.","volume":"20","author":"Zhang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.3748\/wjg.v26.i16.1912","article-title":"Interleukin-6 compared to the other Th17\/Treg related cytokines in inflammatory bowel disease and colorectal cancer.","volume":"26","author":"Velikova","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"1168188","DOI":"10.3389\/fimmu.2023.1168188","article-title":"Association between inflammatory bowel disease and interleukins, chemokines: a two-sample bidirectional mendelian randomization study.","volume":"14","author":"Fang","year":"2023","journal-title":"Front Immunol"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cyto.2015.10.008","article-title":"Chemokine and cytokine levels in inflammatory bowel disease patients.","volume":"77","author":"Singh","year":"2016","journal-title":"Cytokine"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s12026-016-8804-z","article-title":"Interleukin 27 is up-regulated in patients with active inflammatory bowel disease.","volume":"64","author":"Furuzawa Carballeda","year":"2016","journal-title":"Immunol Res"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"9386","DOI":"10.1038\/s41598-019-45747-2","article-title":"Interleukin-18 as a drug repositioning opportunity for inflammatory bowel disease: a Mendelian randomization study.","volume":"9","author":"Mokry","year":"2019","journal-title":"Sci Rep"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/ijc.34214","article-title":"Causal relationships between inflammatory factors and multiple myeloma: a bidirectional Mendelian randomization study.","volume":"151","author":"Wang","year":"2022","journal-title":"Int J Cancer"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"1376800","DOI":"10.3389\/fendo.2024.1376800","article-title":"Mendelian randomization reveals the impact of diet on infertility in men and women.","volume":"15","author":"Chen","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"1358416","DOI":"10.3389\/fendo.2024.1358416","article-title":"Association between circulating immune cells and the risk of prostate cancer: a Mendelian randomization study.","volume":"15","author":"Hao","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"1206290","DOI":"10.3389\/fneur.2023.1206290","article-title":"Assessment of the relationship between generalized convulsive epilepsy and systemic inflammatory regulators: a bidirectional Mendelian randomization study.","volume":"14","author":"Wang","year":"2023","journal-title":"Front Neurol"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"1242614","DOI":"10.3389\/fgene.2023.1242614","article-title":"Genetically predicted circulating levels of cytokines and the risk of depression: a bidirectional Mendelian-randomization study.","volume":"14","author":"Wang","year":"2023","journal-title":"Front Genet"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"1364157","DOI":"10.3389\/fendo.2024.1364157","article-title":"Thyroid function and polycystic ovary syndrome: a Mendelian randomization study.","volume":"15","author":"Zhao","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajhg.2016.11.007","article-title":"Genome-wide association study identifies 27 loci influencing concentrations of circulating cytokines and growth factors.","volume":"100","author":"Ahola-Olli","year":"2017","journal-title":"Am J Hum Genet"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations.","volume":"47","author":"Liu","year":"2015","journal-title":"Nat Genet"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"1397670","DOI":"10.3389\/fendo.2024.1397670","article-title":"Causal association of immune cells and endometriosis: a Mendelian randomization study.","volume":"15","author":"Fang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"e28734","DOI":"10.1002\/jmv.28734","article-title":"Association of gut microbiota with COVID-19 susceptibility and severity: a two-sample Mendelian randomization study.","volume":"95","author":"Shang","year":"2023","journal-title":"J Med Virol"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"1332383","DOI":"10.3389\/fendo.2023.1332383","article-title":"The causal relationship between 41 inflammatory cytokines and hypothyroidism: bidirectional two-sample Mendelian randomization study.","volume":"14","author":"Lai","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"1287463","DOI":"10.3389\/fendo.2023.1287463","article-title":"Causal association between obesity and hypothyroidism: a two-sample bidirectional Mendelian randomization study.","volume":"14","author":"Qiu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"1343367","DOI":"10.3389\/fendo.2023.1343367","article-title":"A two-sample Mendelian randomization analysis excludes causal relationships between non-alcoholic fatty liver disease and kidney stones.","volume":"14","author":"Li","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"1332712","DOI":"10.3389\/fendo.2023.1332712","article-title":"Association between human blood metabolome and the risk of delirium: a Mendelian randomization study.","volume":"14","author":"Long","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"W214","DOI":"10.1093\/nar\/gkq537","article-title":"The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function.","volume":"38","author":"Warde-Farley","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"W185","DOI":"10.1093\/nar\/gkaa420","article-title":"SNPnexus: a web server for functional annotation of human genome sequence variation (2020 update).","volume":"48","author":"Oscanoa","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"baz046","DOI":"10.1093\/database\/baz046","article-title":"PanglaoDB: a web server for exploration of mouse and human single-cell RNA sequencing data.","volume":"2019","author":"Franzen","year":"2019","journal-title":"Database (Oxford)"},{"key":"R30-20260915","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2249.1995.tb03721.x","article-title":"Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD).","volume":"100","author":"Kucharzik","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"R31-20260915","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1159\/000509110","article-title":"Predisposition of inflammatory bowel disease is influenced by IL-8, IL-10, and IL-18 polymorphisms: a meta-analysis.","volume":"181","author":"Su","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"R32-20260915","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bbrc.2019.01.123","article-title":"Ascl2 facilitates IL-10 production in Th17 cells to restrain their pathogenicity in inflammatory bowel disease.","volume":"510","author":"Yi","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"R33-20260915","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1365-2249.1998.00625.x","article-title":"Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility.","volume":"113","author":"Parkes","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"R34-20260915","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.immunol.21.120601.141142","article-title":"IL-13 effector functions.","volume":"21","author":"Wynn","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"R35-20260915","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.2174\/13894501113149990170","article-title":"Anti-IL-13 in inflammatory bowel disease: from the bench to the bedside.","volume":"14","author":"Jovani","year":"2013","journal-title":"Curr Drug Targets"},{"key":"R36-20260915","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1089\/dna.2012.1692","article-title":"The lL-8 and IL-13 gene polymorphisms in inflammatory bowel disease and colorectal cancer.","volume":"31","author":"Walczak","year":"2012","journal-title":"DNA Cell Biol"},{"key":"R37-20260915","doi-asserted-by":"crossref","first-page":"eabq6509","DOI":"10.1126\/sciimmunol.abq6509","article-title":"CXCL9 and CXCL10 bring the heat to tumors.","volume":"7","author":"Reschke","year":"2022","journal-title":"Sci Immunol"},{"key":"R38-20260915","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation \u2013 a target for novel cancer therapy.","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"R39-20260915","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1038\/s41598-021-86251-w","article-title":"Serum biomarkers confirming stable remission in inflammatory bowel disease.","volume":"11","author":"Kessel","year":"2021","journal-title":"Sci Rep"},{"key":"R40-20260915","doi-asserted-by":"crossref","first-page":"9754","DOI":"10.1038\/s41598-023-36833-7","article-title":"CXCL10 as a shared specific marker in rheumatoid arthritis and inflammatory bowel disease and a clue involved in the mechanism of intestinal flora in rheumatoid arthritis.","volume":"13","author":"Guan","year":"2023","journal-title":"Sci Rep"},{"key":"R41-20260915","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/01.MIB.0000178263.34099.89","article-title":"Anti-interferon-inducible chemokine, CXCL10, reduces colitis by impairing T helper-1 induction and recruitment in mice.","volume":"11","author":"Hyun","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"R42-20260915","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.4049\/jimmunol.171.3.1401","article-title":"Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10-\/- mice.","volume":"171","author":"Singh","year":"2003","journal-title":"J Immunol"},{"key":"R43-20260915","doi-asserted-by":"crossref","first-page":"S641","DOI":"10.1093\/ecco-jcc\/jjx145","article-title":"Chemokines and chemokine receptors as therapeutic targets in inflammatory bowel disease; pitfalls and promise.","volume":"12","author":"Trivedi","year":"2018","journal-title":"J Crohns Colitis"},{"key":"R44-20260915","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/jcb.27049","article-title":"MIP-1alpha induces inflammatory responses by upregulating chemokine receptor 1\/chemokine receptor 5 and activating c-Jun N-terminal kinase and mitogen-activated protein kinase signaling pathways in acute pancreatitis.","volume":"120","author":"Wu","year":"2019","journal-title":"J Cell Biochem"},{"key":"R45-20260915","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00054725-199606000-00004","article-title":"Chemokines in inflammatory bowel disease mucosa: expression of RANTES, macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and gamma-Interferon-Inducible Protein-10 by Macrophages, lymphocytes, endothelial cells, and granulomas.","volume":"2","author":"Grimm","year":"1996","journal-title":"Inflamm Bowel Dis"},{"key":"R46-20260915","doi-asserted-by":"crossref","first-page":"1276257","DOI":"10.3389\/fimmu.2023.1276257","article-title":"Associations of genetically predicted circulating levels of cytokines with telomere length: a Mendelian randomization study.","volume":"14","author":"Pan","year":"2023","journal-title":"Front Immunol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045312","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:01:23Z","timestamp":1789498883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000045312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":46,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045312","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"2025-07-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}